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ABSTRACT 
 In the past decades, the development of nanotechnology has had tremendous 
successes in material science. In this technology, the pertinent materials are used at 
the intermediate scale between individual molecules and their size in the nanometer 
region(1-100nm) compared to bulk materials. This nanoscale size provides a larger 
surface area; therefore, nanoparticles would be perfect essential components of 
nanotechnology. The reduced size of nanoparticles has a larger surface ratio to 
volume, which can modify their chemical, mechanical, structural, and electrical 
properties.  
 In this study, the main goal is to test different metal related nanoparticles, such as 
CuNPs (Copper nanoparticles), FeNPs (Iron nanoparticles), CuHARS (Copper high-aspect 
ratio structure) and, Zn (Zinc microparticles) with different biological environments. 
In specific biological environments, such as sterilized water, deionized water, and 
various cell culture media, nanoparticles will change their morphology in different 
degrees; also, in living cells (astrocyte and CRL rat brain glioma cells) environment 
these nanoparticles either damage the cells or would not harm the cells. 
 The hypothesis of this project is that CuHARS or CuNPs under biological 
conditions would degrade. In order to prove this hypothesis as valid, CuHARS with 
CuNPs were tested in sterilized water and cell culture media at room temperature and 
body temperature. The result showed that CuHARS and CuNPs will degrade in cell 
iv 
culture media at room temperature and body temperature at different pace. 
Surprisingly, CuHARS and CuNPs in sterilized water are aggregated in different 
levels. Charges around the nanoparticles cause them to aggregate or evenly disperse 
in water, but they do not degrade. After the testing, image analysis methods were 
used to extrapolate nanoparticles as either aggregating, degrading, or more stable.   
  After testing FeNPs in astrocyte cells and CRL rat brain glioma cancer cells, 
the hypothesis was that FeNPs would not affect morphology of the cells. Results 
showed that astrocyte and CRL rat brain glioma cancer cells were not damaged and 
were healthy. However, other nanoparticles, such as CuNPs and, CuHARS have 
toxicity by nature, they harmed the normal astrocyte and CRL rat brain glioma cancer 
cells. 
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CHAPTER 1 
 
INTRODUCTION 
 
                                      1.1      Metal Related Nanoparticles 
 In nanotechnology, nanoparticles are fundamental building blocks for various 
applications. Nanoparticles exist with great chemical diversity in the form of metals, 
metal oxides, semiconductors, polymers, carbon materials, organics and biological 
based compounds [1]. Due to nanoparticle’s very small size, which ranges from 1-
100nm, they have very large surface area per unit to volume, which gives them unique 
properties. Nanoparticles exhibit different morphology, such as, sphere, cylinder, 
platelets, hollow spheres and tubes. Small sized nanoparticles have numerous potential 
applications in material engineering, health and biomedicine, chemistry, food industry, 
personal care products, electronics and computers. 
Nanoparticles are made from materials with different chemical natures. Most of 
the nanoparticles are metals, metal oxide, polymers, silicates, carbon, and biomolecules. 
Many nanomaterials are metal-based nanoparticles, such as gold and silver nanoparticles, 
nanometallic oxides (zinc oxide, titanium oxide, iron oxide, and copper oxide), and are 
applied for many uses [2]. Metal-based nanoparticles, in particular silver and copper 
nanoparticles have a toxic nature that causes concern for their production uses.  
Over the past decades, metal-based nanoparticle production has been growing 
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exponentially due to its nanoparticles’ enhanced physicochemical properties and 
biological activities compared to their bulk parent materials [3].  
Iron nanoparticles (FeNPs) are sub micrometer particles of iron metal. Nanosized 
FeNPs are highly reactive due to their high surface area. FeNPs are unique to other metal-
based nanoparticles because of their magnetic properties. When iron particles are below a 
certain size range, <50nm, their chemical and physical properties react differently under 
different environments. The positively charged surface of FeNPs interact strongly with 
the negatively charged cell environment [4]. This allows the FeNPs to be useful in 
biotechnology, improved MRI imaging, and treating and cleaning up the contamination 
in ground water.  
Copper nanoparticles (CuNPs) are copper based particle size, ranging from 1-
100nm. CuNPs are abundant and inexpensive copper metals, which by manufacturing, 
and synthesis are easily made. Copper nanoparticles can be used in many different areas, 
such as catalysis, metallic coating, ink and biocide. By nature, CuNPs are a toxic and 
smaller size. Also, higher concentration of CuNPs has a highly toxic effect. The toxicity 
of Copper nanoparticles is size and concentration dependent [5]. When copper 
nanoparticles are exposed to different environments their surface morphology changes. 
When copper nanoparticles are in a biological environment, they undergo various 
reactions with different components of the environment; thus, the environmental 
condition (e.g. solution pH, ionic strength, natural organic matter) that the CuNPs are in 
plays an important role in their aggregation, degradation and agglomeration [3].  
Zinc nanoparticles (ZnNPs) are one of the most commonly used nanoparticles in 
the biomedical field. The most widespread type of Zinc nanoparticles (ZnNPs) are zinc 
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oxide (ZnO) nanoparticles. ZnO nanoparticles are believed to be non-toxic, biosafe, and 
biocompatible, and have been also used as drug delivery carriers, for cosmetics, and 
filling for medical materials [6]. ZnO nanoparticles are reported by other research studies 
as nontoxic to human cells; this aspect necessities their usage as antibacterial agent 
noxious to microorganisms [7].  Antibacterial activities of ZnO nanoparticles are 
dependent on their size, shape, concentration, and exposure time to the bacterial cells [8]. 
CuHARS (copper high-aspect ratio structure) is a novel biohybrid material made 
from copper sulfate and cystine, which has nano- and microscale features [9]. Due to 
CuHARS containing a copper component, it has a toxic nature. It was discovered and 
produced at Dr. DeCoster’s lab, at Louisiana Tech University, Ruston. Since CuHARS 
are nanomaterials that have high surface area ratio to volume so that they can be used for 
targeted drug delivery, bio tracking and tissue engineering. CuHARS are biodegradable 
material that under physiological conditions (37 ºC and 5% CO2) in different cell culture 
media degrade over time [9]. Also, CuHARS in a water environment are extremely 
mobile for certain amount of time after they stabilize but do not degrade at all [9].  
All these nanoparticles have common physical and chemical properties that are 
essential component for nanotechnology. From size to shape, all nanoparticles have 
specific structural, optical, electrical and physicochemical properties [7]. Metal based  
nanoparticles have an important role in determining their mobility, reactivity, toxicity, 
and potential risk in the cell environment due to their large surface area and size.  
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                                     1.2     Research Objectives  
1. Study metal-containing nanomaterials interacting with biological and physical 
environments. The research focus is mainly on CuNPs (copper nanoparticles), CuHARS 
(Copper high-aspect ratio structure) FeNPs (iron nanoparticles), and ZnNPs (zinc 
microparticles). These nanoparticles and microparticles mostly are characterized by their 
size, composition, crystallinity, and morphology. 
2. Study physical behaviors of nanoparticles in different biological and physical 
environments. 
2a. Test nanoparticles in biological and physical environments and observe their reaction 
activities, such as whether they can aggregate, degrade or evenly disperse. Biological 
environments could be sterilized water, deionized water, different types of cell culture 
media at room temperature or body temperature. 
2b. Test nanoparticle’s toxicity. Test nanoparticles in real living cells’ environments. 
Nanoparticles interact with cell biomolecules in a unique manner physically transferring 
into the inner cell structures. Nanoparticles can be tested using primary astrocyte cells 
and CRL 2303 glioma cells (rat brain tumor cells). Toxicity of nanoparticles can affect 
the metabolism of the cells. Nanoparticles can damage the cell’s normal functionality. 
After the cells are treated with nanoparticles, they are either dying, stressed or perhaps 
unaffected. 
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CHAPTER 2 
 
METHODOLOGY 
 
2.1 Iron Nanoparticles 
 There are many research papers which have been published in the past few years 
about applications of iron nanoparticles. Different types of iron nanoparticles are 
available in the market with suitable prices. Over the last few years, iron nanoparticles 
have been synthesized by various methods that meet the needs of nanotechnology. Iron 
nanoparticles are basically iron (III) powder. In this research, Fe2O3 nanopowder was 
purchased from the company Sigma-Aldrich (St. Louis, MO, USA). The particle size is 
less than 50nm, the surface area is50-245 m2/mg and molecular weight is 159.69g/mol. 
Fe2O3 nanopowder was diluted in deionized water. Figure 2-1 shows Fe2O3 nanopowder 
and its diluted solution.  
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Figure 2-1: Fe2O3 nanopowder on the left, diluted Fe2O3 nanopowder solution on the 
right. 
After being diluted in the water, the Fe2O3 nanopowder is stored in a clear glass 
vial. The stock solution concentration is 2mg/ml. In order to determine iron 
nanoparticle’s stability, mobility, and other physical dynamics, FeNPs were tested in 
different environmental and biological condition.  
2.1.1  FeNPs in different physical and biological conditions  
In this section, iron nanoparticles were tested under various physical conditions. 
First, iron nanoparticles were tested in sterilized water, deionized water and astrocyte cell 
culture media in an incubator (37 ºC). The iron nanoparticle’s concentrations were diluted 
from stock solution 2mg/ml to 3ug/ml and 6ug/ml. This was performed easily with the 
serial dilution method. After dilution process was done, iron nanoparticles were plated in 
a 48 well suspension culture plate sterilized with a lid. Iron nanoparticles were plated in 
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12 wells total. Each well volume was 1000ul. In order to get the best results, each 
concentration of iron nanoparticles were plated into 2 wells, such as 3ug/ml of iron 
nanoparticles plated into 2 wells in sterilized water, deionized water and astrocyte cell 
culture media. 6ug/ml of iron nanoparticles were plated using the same method as 
3ug/ml. After plating the iron nanoparticles, they were stored in the incubator for 1-4 
days to check their stability and mobility in such an environment. This whole experiment 
was performed by maintaining a sterilized flow hood.   
Second, iron nanoparticles under sonicated and non-sonicated conditions were 
tested with DPBS (Dulbecco’s Phosphate-Buffered Saline) solution. DPBS solution was 
purchased from the Gibco life technology company, Carlsbad, California. DPBS is a  
balanced salt solution used for a variety of cell culture applications, such as washing the 
cell before dissociation, transporting the cells, diluting cells for counting and preparing 
for reagent. The DPBS solution used in this procedure has a pH range of 6.7-7.0 without 
Calcium Chloride and Magnesium. Iron nanoparticles were diluted from the same stock 
solution 2mg/ml to 2ug/ml and 5ug/ml with the same method used the in previous 
section. In this experiment, in order to get consistent pictures for results, iron 
nanoparticles were tested in sonicated and non-sonicated conditions. Iron nanoparticles 
were sonicated for 20 mins before plating them into the plate. Sonication was carried out 
by Branson 1800, and ½ gallon ultra-sonic cleaner, 40kHz. This experiment also used 48 
well suspension culture plate sterilized with a lid. Iron nanoparticles were plated into two 
separated plates: one plate was used for non-sonicated iron nanoparticles with a 
concentration 2ug/ml and 5ug/ml; another plate used for sonicated iron nanoparticles 
with concentration of 2ug/ml and 5ug/ml. the volume of each well was 1000ul. The 
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whole experiment was operated under a sterilized flow hood. After the experiment was 
done, plates were stored in the incubator for 1-7 days. During this time period, 
nanoparticles were checked by an electronic digital camera installed with microscope to 
observe their physical behavior in the DPSB solution.  
Finally, iron nanoparticles were tested with living cell environments to check 
whether they would harm the cells. In this section, iron nanoparticles were tested with 
astrocyte cells and CRL2303 glioma cells. Primary astrocyte cells were growing from 
stage 1 to stage 6. Astrocyte cells were regularly fed and split.  After stage 6, astrocyte 
cells were plated into the 48 well cell culture plate sterilized with a lid. When plating the  
cells, the process was completed, and the cell culture plate was stored in the incubator 
(37ºC). Astrocyte cells grow slower than CRL2303 glioma tumor cells. Usually, after 3-4  
days after the cells can be treated with iron nanoparticles. Each well contains 10,000 
astrocyte cells. Iron nanoparticles were diluted from 2mg/ml to 5ug/ml. After treating the 
cells with iron nanoparticles, the cell culture plate was stored in the incubator. The cell 
culture plate was checked by the electronic digital camera with scope regularly over time 
to see if iron nanoparticles would harm the cells or if they wouldn’t affect the cells 
morphology at all.  
                                                     2.2      Copper Nanoparticles   
   Copper is one of the most used and important industrial metal. Since copper 
nanoparticles have different physiochemical properties, they are used for biocide, facial 
spray, catalysis, sensors, microelectronics, and different electrical applications. Copper 
nanoparticles can be easily purchased from the market. There are many ways to prepare 
and synthesize the copper nanoparticles. The preparation process will be challenging 
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because copper nanoparticles easily oxidized with air. Various methods are used for 
synthesis of the copper nanoparticles, such as chemical reduction method, the microwave 
method, the electrochemical method and, biological synthesis. [10]. In this study, copper 
nanoparticles were purchased from the company Sigma-Aldrich (St. Louis, MO, USA). 
Copper nanopowder particle size is less than 100nm and 98.8% trace metal basis.    In 
order to test copper nanoparticles with other materials, it needs to be changed to copper 
nanoparticle solution from nonopowders. Usually it can be made into a stock solution  
with concentration of 2mg/ml.   
2.2.1 Copper nanoparticle and CuHARS in different physical and biological 
conditions 
In this section, copper nanoparticles and copper related CuHARS were tested in 
different environments to determine their mobility, reactivity, stability and toxicity. 
First, copper nanoparticles were tested in sterilized water, deionized water, astrocyte cell  
culture media in the incubator (37ºC). Copper nanoparticles were diluted from stock 
solution with concentration of 2mg/ml to 3ug/ml and 6ug/ml. This process used serial 
dilution. 
After dilution copper nanoparticles were ready to plate into a 48 well suspension 
culture plate that was sterilized with a lid. Each well volume is 1000ul. In order to better 
analyze the data each concentration of copper nanoparticles was plated into two wells. 
Overall, 3ug/ml and 6ug/ml concentration of copper nanoparticles were plated to 12 
wells. After the experiment was completed, plates were stored in the incubator (37ºC). 
For tracking copper nanoparticle’s physical behavior, the digital electronic microscope 
was used.  
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Second, CuHARS (Copper high-aspect ratio structure) was tested at room 
temperature with different concentrations in astrocyte cell culture media. CuHARS were 
provided by Dr. DeCoster’s lab at Louisiana Tech, Ruston. In this section before using 
the CuHARS, particles in stock solution concentration of 2mg/ml were sonicated for 
30mins mins with Branson 1800, and ½ gallon ultra-sonic cleaner, 40kHz. After the 
sonication process was done, CuHARS were diluted from 2mg/ml to 1ug/ml,2ug/ml and  
4ug/ml with a serial dilution method. For this experiment, the 48 well suspension culture  
plate sterilized with a lid was used. A total of 3 wells were plated for 3 different 
concentrations, and each well volume was 500ul. After the experiment, the plate was put 
on one of the shelves at lab room temperature of 22 ºC. At room temperature, molecular 
dynamics are slower than body temperature, so the whole process for tracking of 
CuHARS biocompatibility took 1 to 3 weeks, and digital the electronic microscope was 
used. 
Third, copper nanoparticles and CuHARS in astrocyte cell culture have different 
degrees of reaction rates. CuHARS and copper nanoparticles were plated together in the 
same well in order to determine reactivity, aggregation and degradation rate. CuHARS 
were diluted to 10ug/ml from 2mg/ml, and copper nanoparticles were diluted to 5ug/ml. 
Both CuHARS and copper nanoparticles were sonicated for 20mins with Branson 1800, 
and ½ gallon ultra-sonic cleaner, 40kHz. Afterwards, sonicated CuHARS and copper 
nanoparticles were plated into the suspension plate. After plating, the plates were stored 
in the incubator (37ºC) for 1-5 days. For the tracking of the physical behavior of 
combined particles, electronic digital microscope was used.  
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Finally, it must be considered that copper nanoparticles are toxic by nature. In this 
section in order to determine toxicity of the copper nanoparticles, they were treated with 
astrocyte cells and CRL2303 glioma rat cancer cells.  After growing astrocyte and glioma 
cells, they were prepared for plating. During the growing section, astrocyte cells were 
regularly fed with astrocyte cell culture media, and glioma cells were regularly fed with  
CRL 2303 cell culture media. Usually, glioma cells grow faster than astrocyte cells. In 
this section, cells were plated to 48 well cell culture plate sterilized with a lid. Astrocyte 
cells were plated into 6 wells, 2 for control, each well contains 10,000 cells. Glioma cells 
also plated into 6 wells, 2 for control, each well contains 5000 cells. After plating the 
cells, plates were stored in the incubator (37ºC) for growing. Usually, it takes 2-4 days to 
grow the cells. In the last step, cells are treated with copper nanoparticles. Copper 
nanoparticles are diluted from stock solution of 2mg/ml to 5ug /ml and 10ug/ml. After 
cells were treated with copper nanoparticles, they were stored in the incubator. For the 
tracking step, to determine if copper nanoparticles affect the morphology of cells, the 
electronic microscopic with a digital camera was used. At the end, DAPI staining was 
used for the analysis of cell morphology. DAPI is a fluorescent stain that strongly binds 
to cell nuclei.   
2.3   Zinc Nanoparticles 
Zinc is an essential element in the human system, and with functional, strategic, 
promising, and versatile inorganic materials with a broad range of applications. Zinc 
Oxide nanoparticles hold unique optical, chemical sensing, semiconducting, electric 
conductivity, and piezo electric properties [7]. Nanosized Zinc Oxide particles are non-
toxic to the human body; however, they have had antibacterial properties from time 
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immemorial [8]. Zinc Oxide nanoparticles can be synthesized through various methods 
by controlling the synthesis parameters [7]. With various synthesis methods, Zinc Oxide 
nanoparticles can be produced with a different morphology, such as microwave 
decomposition method making sphere shape, hydrothermal technique making nanorods 
[7]. In this study, Zinc-cystine microparticles were synthesized at Dr. DeCoster’s lab in 
Louisiana Tech University, Ruston. It used the self-assembly method, which produced 
different shapes of Zinc-cystine microparticles, such as hexagonal prismatic rods, 
dumbbell, and rod shaped.  
2.3.1  Zinc microparticles in different physical and biological environments 
Since Zinc-cystine microparticles have different morphologies under different 
synthesis methods, in this section Zinc-cystine microparticles were tested with sterilized 
water and astrocyte cell culture media to determine mobility and stability of Zinc-cystine 
microparticles.  
   First, Zinc-cystine microparticles were synthesized at Dr. DeCoster’s lab in 
Louisiana Tech University, Ruston. With the self-assembly method, which formed a 
hexagonal prismatic shape and rod shape. Zinc-cystine microparticles were diluted from 
solution to different molar concentrations and were tested with sterilized water. Two 
different shapes of Zinc-cystine microparticles were plated into the 48 well suspension 
culture plate sterilized with a lid to test their physical morphology. After the experiment 
was done, plates were stored in the incubator (37ºC). Plates stayed in the incubator for 1-
4 days, and Zinc-cystine microparticles’ physical activity was tracked by the electronic 
microscope with the digital camera.  
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Second, Zinc-cystine microparticles were also tested with astrocyte cell culture 
media to determine if microparticles are biodegradable in the cell culture media. The 
whole experiment, just as the Zinc-cystine microparticles was tested with sterilized water. 
                                        2.4  Cell Culture 
Brain tissues were taken from newborn (less than 3 days old) rat pups. In order to 
separate brain tissue, trypsin was used in combination with trituration, and work was  
done in a 15ml tube. After allowing the bulk tissue to settle down, the supernatant 
containing the desired cells was removed from the tube and put into another 15ml tube.  
This process was repeated at least three times to maximize the cell yield. Primary cells 
can grow for many stages: usually astrocyte cells can grow for 7 stages, and glioma cells 
can grow from15-19 stages. Before plating the cells, cells are taken from the flask and 
washed with a PBS 1X solution. After cells are washed, trypsin was added to lifting cells 
from the flask which was put back into the incubator (37ºC) for 5-7 mins. After the cells 
are taken from the flask, they are moved to a tube that is then ready to be centrifuged. 
Once 15ml of the tube is completely full of the supernatant, it was centrifugated for 8 
mins at a radial centrifugal force (RCF) of 160 and resulted in cell pellets, which were 
formed at the bottom of the tube.  The supernatant was sucked from the tube and fresh 
new neuronal culture media was added. After adding the fresh media, the pellet was 
broken up by mild vortexing. A hemocytometer was used for counting the number of 
living cells under trypan blue added to the cells.  Next, cells were plated into 48 well cell 
culture plate sterilized with a lid. The density of 10,000 cells were plated into the 48 well 
cell culture plate. The rest of the cells from the tube were stored in the flask with a cell 
density of over a million cells. Plated cells and the flask stored in the incubator (37ºC) for 
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several days to grow. For plated cells growing in the incubator (37ºC), astrocyte cells 
usually take 1-4 days, and glioma cells take 1-3 days. Before treating the cells with  
nanoparticles, cells are washed by new fresh cell culture media to remove some debris 
from the plate. Cells in the flask are fed by cell culture media to grow. After cells are 
grown in the plate, they were treated with copper nanoparticles and iron nanoparticles.  
Cell culture media ingredients are given in appendix A and B. Cell culture protocol is 
given by Dr. DeCoster’s lab. 
                                    2.5  Digital Microscopy 
For most of the microscopy work was done by Olympus 1X51 inverted 
microscope. The IX51 inverted system microscope addresses the observation and 
imaging needs of high-level laboratory and clinical applications. Fluorescent imaging 
was taken by the EXFO X-Cite series 120 light source. For DAPI stained nuclei, 
excitation light in the ultraviolet range (~400nm) was used. 
                                               2.6       Image Analysis  
All image analysis work was done by open source software Image J 1.52. Image J 
is a java-based image processing program developed at National Institute of Health and 
the Laboratory for Optical and Computational Instrumentation (LOCI, University of 
Wisconsin). Image J was used to count numbers of nanoparticles, cells and surface areas 
of total number of cells and nanoparticles in each single image. For each image, Image J  
program was able to show each nanoparticle’s surface area. From the surface area, the 
nanoparticle’s morphology was easily determined, including which nanoparticles were 
slowly degrading or aggregating. Image J also can determine cell morphology, such as, 
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whether cell’s nuclei were shrinking or expanding. Example of how the program was 
used given in the APPENDIX C. 
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CHAPTER 3 
 
RESULTS   
 
3.1 Iron Nanoparticles in Different Biological and Physical Environments 
Nanoparticles’ shapes, sizes, and compositions are important to determine their 
physical morphology in different environments. Sonicated iron nanoparticles were tested 
in astrocyte cell culture media, sterilized water, and deionized water. Figures 3.1 to 3.6 
show iron nanoparticles’ activity in different biological environments. 
 
 
Figure 3.1: 6ug/ml of Iron nanoparticles in the astrocyte cell culture media. Picture 
was taken 30 mins after the experiment was completed. 10x magnification 
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Both Figure 3.1 and Figure3.2 images show that iron nanoparticles in the 
astrocyte cell culture media from day 0 - day 4 in the incubator(37ºC) changed their 
morphology. Iron nanoparticles didn’t degrade, instead particles were clumped together.  
Figure 3.3 and Figure3.4 iron nanoparticles showed unique physical mobility over 
time in the sterilized water in the incubator (37ºC). Iron nanoparticles changed their 
morphology from chain shape to aggregate into a net shape.  
Figures 3.5 to 3.6 show how iron nanoparticles kept their morphology the same 
over time. From day 1 to day 4, images show that iron nanoparticles have strong stability  
in the deionized water environment.  
 
 
 
 
 
 
Figure 3.2: 6ug/ml of Iron nanoparticles in the astrocyte cell culture media. Picture 
was taken 4 days after the experiment was completed. 10x magnification. Over 4 
days 6ug/ml of iron nanoparticles were clumped together.  
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Figure 3.3: 6ug/ml of Iron nanoparticles in sterilized water. Picture was taken 1 hour 
after when FeNPs plated into the sterilized water in the incubator (37ºC). 10x 
magnification. 
 
Figure 3.4: 6ug/ml of Iron nanoparticles in the sterilized water. Picture was taken after 
4 days when FeNPs are plated onto the sterilized water in the incubator (37ºC). Over 4 
days FeNPs are changed their morphology from chain shape to net shape. 10x 
magnification. 
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Figure 3.5: 6ug/ml of Iron nanoparticles in the deionized water. Picture was taken 
1hour after when FeNPs are plated onto the deionized water in the incubator (37ºC). 
10x magnification. 
 
Figure 3.6: 6ug/ml of Iron nanoparticles in the deionized water. Picture was taken 4 
days after when FeNPs are plated onto the deionzed water in the incubator (37ºC). 
Over 4 days nothing has changed. Particles were stable. 10x magnification. 
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3.2 Iron Nanoparticles in DPBS Solution 
Sonicated and non-sonicated iron nanoparticles were tested in the DPBS 1x 
solution to determine their physical morphology. Figures 3.7 to 3.10 show activity of iron 
nanoparticles in the DPBS solution in the incubator (37ºC). Figure 3.7 and 3.8 show, 
morphology of non-sonicated FeNPs in the DPBS1x solution.  
 
 
Figure 3.7: Non-sonicated 2ug/ml of iron nanoparticles in the DPBS1x solution. 
Picture was taken 1hour after iron nanoparticles added. 10x magnification. 
Figure 3.9 and 3.10 show sonicated iron nanoparticle’s morphology in the 
DPBS1x solution at body temperature.  
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Figure 3.8: Non-sonicated 2ug/ml of iron nanoparticles in the DPBS1x solution. 
Picture was taken 3days after when iron nanoparticles were added. 10x magnification. 
 
Figure 3.9: Sonicated 2ug/ml of iron nanoparticles in the DPBS1x solution. Picture 
was taken 5hours after when iron nanoparticles were added. 10x magnification. 
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Figure 3.10: Non-sonicated 2ug/ml of iron nanoparticles in the DPBS1x solution. 
Picture are taken day3 after iron nanoparticles were added. 10x magnification.   
Iron nanoparticles have different activities in the DPBS 1x solution in the 
incubator (37ºC). Non-sonicated iron nanoparticles were slowly aggregated to long chain 
shapes over time. Sonicated iron nanoparticles changed their morphology from high 
density disperse into clumped chain shape.  
                     3.3    Iron Nanoparticles in The Living Cell Environment 
In order to determine whether iron nanoparticles are affecting the growth rate of 
the living cells, particles were tested with astrocyte cells and CRL2303 glioma rat cancer 
cells. Figures 3.11 to 3.16 show how iron nanoparticles affect the cells’ morphologies. 
Figure 3.11 shows 10,000 control astrocyte cells without iron nanoparticles treated. 
Figure 3.12 shows 10,000 astrocyte cells were treated with 10ug/ml of iron nanoparticles. 
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Figure 3.11: 10,000 astrocyte cells in the cell culture plate. The Picture is shown as a 
control cells to compare with other cells are treated with iron nanoparticles. Picture 
was taken 17 hours after when cells are treated with iron nanoparticles. Picture 
represents small portion of 10,000 astrocyte cells in single cell culture plate well. 10x 
magnification.   
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Figure 3.12: 10,000 astrocyte cells treated with 10ug/ml of iron nanoparticles. Picture 
was taken 17 hours after cells were treated with iron nanoparticles. Picture represents 
small portion of 10,000 astrocyte cells in single cell culture plate well. within 17 hours 
iron nanoparticles already aggregated and clumped. 10x magnification.   
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In the Figure 3.12a shows 10,000 astrocyte cells are treated with concentration of 
10ug/ml iron nanoparticles. Circle A shows some iron nanoparticles are started clump 
when they attached to the cell membrane within 17 hours. Circle B shows other iron 
nanoparticles in the space between cells are did not clump but they are aggregated in 
different degrees. Although iron nanoparticles didn’t break down, but they are not toxic. 
 
 
  
 
Figure 3.12a: Aggregation and clumping of 10ug/ml of iron nanoparticles with10,000 
astrocyte cells. Picture represents small portion of 10,000 astrocyte cells in single cell 
culture plate well. 10x magnification.   
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Figure 3.13: 10,000 astrocyte cells were treated with 10ug/ml of iron nanoparticles. 
The picture was taken 8 days after cells were treated with iron nanoparticles. Picture 
represents small portion of 10,000 astrocyte cells in single cell culture plate well.10x 
magnification. 
 
Figure 3.14: 10,000 astrocyte cells control plate without treated with iron 
nanoparticles. The picture was taken 8 days after cells were treated with iron 
nanoparticles. Picture represents small portion of 10,000 astrocyte cells in single cell 
culture plate well. 10x magnification.   
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From Figures 3.11 to 3.14, 10,000 astrocyte cells are shown treated with 10ug/ml 
of iron nanoparticles to test whether nanoparticles are harmful to a cells’ morphology or 
the normal functionality. Images show that after treating astrocyte cells with iron 
nanoparticles, the cells are growing normally and didn’t change their morphology over 8 
days. Control cells are growing normally for 8 days. During these 8 days, fresh astrocyte 
cell culture media was added to the well to feed the cells. During the changing cell 
culture media process iron nanoparticles in the space between cells were sucked out but 
other iron nanoparticles were attached to the cells are stayed and clumped.   
Iron nanoparticles were also used with 5000 CRL 2303 glioma rat cancer cells. 
Glioma cells by nature grow faster than astrocyte cells. Figures 3.15 to 3.17 show how 
iron nanoparticles interact with CRL 2303 glioma cells and affect cell morphology in the 
incubator (37ºC). 
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Figure 3.15: 5000 CRL 2303 glioma cells were treated with 5ug/ml of sonicated iron 
nanoparticles. The picture was taken 2 hours after cells were treated with iron 
nanoparticles in the incubator (37ºC). 10x magnification.  Picture represents small 
portion of 5000 CRL 2303 glioma cells in single cell culture plate well. 
 
 
 
Figure 3.16: 5000 CRL 2303 glioma cells, control cells without iron nanoparticles 
treated. The picture was taken 2 hours after other cells treated with iron 
nanoparticles. Picture represents small portion of 5000 CRL 2303 glioma cells in 
single cell culture plate well.  10x magnification.    
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Figure 3.17: 5000 CRL 2303 glioma cells were treated with 5ug/ml of iron 
nanoparticles. The picture was taken 3 days after cells were treated with iron 
nanoparticles in the incubator (37ºC).  Picture represents small portion of 5000 CRL 
2303 glioma cells in single cell culture plate well. 10x magnification.   
 
Figure 3.18: 5000 CRL 2303 glioma control cells without iron nanoparticles shown. 
The picture was taken 3 days after cells growing without iron nanoparticles were 
treated in the incubator (37ºC).  Picture represents small portion of 5000 CRL 2303 
glioma cells in single cell culture plate well. 10x magnification.   
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From Figure 3.15 to 3.18 5000 CRL 2303 glioma rat cancer cells are shown 
treated with a concentration of 5ug/ml of sonicated iron nanoparticles. CRL 2303 glioma 
rat cancer cells grow very fast, so within 3 days the cells have spread to every edge of the 
well. Figure 3.15 and Figure 3.17 show cells growing normally, and iron nanoparticles 
not impacting the cell’s morphology. In the Figure 3.17 iron nanoparticles are clumped 
and attached to the cell membrane.  Figure 3.16 and Figure 3.18 show how fast cells can 
grow. 
                         3.4  Copper Nanoparticles in Biological Environments 
Copper nanoparticles are characterized by small size between 10-100nm, which 
accounts for their good interactions with different biological environment, such as 
sterilized water, deionized water, different type of cell culture media, astrocyte cells, and 
CRL 2303 glioma rat cancer cells. High surface area and particle size determined copper 
nanoparticle’s activity, mobility, and stability.  Figures 3.19 to 3.24 show copper 
nanoparticles have different morphologies in different biological environments. Figure 
3.19shows, 6ug/ml of CuNPs are added into the astrocyte cell culture media. Figure 3.20 
shows degradation of the CuNPs in the astrocyte cell culture media at body temperature.  
The Figure 3.2o shows CuNPs in the well are completely disappeared.  
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Figure 3.19: 6ug/ml of non-sonicated copper nanoparticles in the astrocyte cell 
culture media. The picture was taken 15mins after copper nanoparticles added to 
astrocyte cell culture media in the incubator (37ºC). 10x magnification.   
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Figure 3.20: 6ug/ml of non-sonicated copper nanoparticles in the astrocyte cell culture 
media. The picture was taken 12hours after copper nanoparticles added to the astrocyte 
cell culture media in the incubator (37ºC). 10x magnification.    
  Figure 3.21 shows, 6ug/ml of CuNPs are added into the sterilized water in the 
incubator (37ºC).  Figure 3.22 shows, aggregation of CuNPs in the sterilized water at 
body temperature.  
 Copper nanoparticles were tested in the deionized water to observe whether 
CuNPs are able to degrade or aggregate. Figure 3.23 shows 6ug/ml of CuNPs were tested 
in the deionized water. Figure 3.24 shows, morphology of CuNPs in the deionized water.   
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Figure 3.21: 6ug/ml of non-sonicated copper nanoparticles in the sterilized water. 
The picture was taken 15mins after copper nanoparticles added to the sterilized water 
in the incubator (37ºC).  10x magnification.   
 
Figure 3.22: 6ug/ml of non-sonicated copper nanoparticles in the sterilized water. 
The picture was taken 4 days after copper nanoparticles added to the sterilized water 
in the incubator (37ºC). 10x magnification.     
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Figure 3.23: 6ug/ml of non-sonicated copper nanoparticles in the deionized water. 
The picture was taken 15 mins after copper nanoparticles added to the deionized water 
in the incubator (37ºC). 10x magnification.  
 
  
 
Figure 3.24: 6ug/ml of non-sonicated copper nanoparticles in the deionized water. 
The picture was taken 24hours after copper nanoparticles added to the deionized water 
in the incubator (37ºC).  10x magnification.    
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Figure 3.25 showed 6ug/ml copper nanoparticles in astrocyte media degrades over 
time. Comparing to the starting area coverage of copper nanoparticles at 3 hours, the 
copper nanoparticles are decreased by 99.5% by 12 hours. Figure 3.26 shows the 
numbers of copper nanoparticles in the astrocyte cell culture media decrease over time. 
 
 
Figure 3.25: 6ug/ml of non-sonicated copper nanoparticles in the astrocyte media 
degrading over 12 hours. Error bar represents standard deviations. 
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From Figure 3.21 to 3.22, 6ug/ml of copper nanoparticles were plated into the 
sterilized water. Figure 3.22 shows all nanoparticles in the plate were agglomerated into a 
big clump. Results shows nanoparticles in the sterilized water wouldn’t degrade or evenly 
disperse.  Figures 3.23 and 3.24 show 6ug/ml of copper nanoparticles were plated into the 
deionized water, which didn’t change their morphology over 24 hours. Copper 
nanoparticles have high stability in the deionized water and do not move in the deionized 
water. In the deionized water, the zeta potential of copper nanoparticles does not change, 
and the particles stay in the same location over time.  
 
 
 
 
 
Figure 3.26: 6ug/ml of non-sonicated copper nanoparticles in astrocyte media 
degrading over 12 hours. The number of copper nanoparticles are decreasing over 
time. Error bar represents standard deviations. 
0
20
40
60
80
100
120
140
160
0 2 4 6 8 10 12 14
N
m
b
er
 o
f 
p
ar
ti
cl
es
 
Time (hour)
37 
 
 
 
3.5 CuHARS (Copper high-aspect ratio structure) in Astrocyte Cell 
Culture Media 
Figures 3.27 to 3.28 show 4ug/ml CuHARS (Copper high-aspect ratio structure) 
tested in the astrocyte cell culture media for 12 days at a room temperature of 22ºC.    
 Figure 3.27 to 3.28 shows that there are some CuHARS are degraded partially 
over time. Figure 3.28 shows there are still some of the CuHARS that stayed in the well 
and didn’t degrade. Figures 3.29 and 3.30 show the degradation rate of CuHARS in the 
astrocyte cell culture media.  
 
 
Figure 3.27: 4ug/ml of CuHARS (Copper high-aspect ratio structure) tested in the 
astrocyte cell culture media at room temperature 22ºC. The picture was taken on day 
1. 10x magnification.    
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Figure 3.28: 4ug/ml of CuHARS (Copper high-aspect ratio structure) tested in the 
astrocyte cell culture media at room temperature of 22ºC. The picture was taken on 
day 12. 10x magnification.   
 
Figure 3.29: Figure A shown 6ug/ml of Copper nanoparticles completely degraded 
within 12 hours in the astrocyte media. Figure B shown 4ug/ml of CuHARS (Copper 
high-aspect ratio structure) hasn’t completely degraded in 5 days in the astrocyte media. 
10x magnification.      
 
39 
 
 
 
 
Figure 3.30: Degradation of 4ug/ml of CuHARS in the astrocyte cell culture media 
over 12days, showing decreasing number of CuHARS particles over 12 days. Error 
bar represents standard deviations. 
 
Figure 3.31: Degradation of 4ug/ml of CuHARS in the astrocyte cell culture media 
over 12days, showing decreasing the CuHARS’ surface area over 12 days. Error bar 
represents standard deviations. 
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3.6  Combination of CuHARS and CuNPs in The CRL 2303 Cell Culture 
Media 
 Figures 3.31 to 3.34 show combination of sonicated CuHARS and copper 
nanoparticles in the CRL 2303 cell culture media at the same well. 5ug/ml of copper 
nanoparticles were sonicated for 15mins, and 10ug/ml of CuHARS were sonicated for 25 
mins. Figures 3.33 and 3.34 show degradation of combination of CuHARS and copper 
nanoparticles. 
 
 
Figure 3.32: Combination of sonicated 10ug/ml of CuHARS and 5ug/ml of copper 
nanoparticles in CRL 2303 cell culture media at same well in the incubator (37ºC). 
The picture was taken 3hours after particles plated into the well. 10x magnification.    
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Figure 3.33: Combination of sonicated 10ug/ml of CuHARS and 5ug/ml of copper 
nanoparticles in CRL 2303 cell culture at same well in the incubator (37ºC). The 
picture was taken 7 days after particles were plated into the well. 10x magnification. 
 
Figure 3.34: Degradation for combination of CuHARS and copper nanoparticles.  
Decreasing surface area of total 10ug/ml CuHARS and 5ug/ml CuNPs in same well. 
Error bar represents standard deviations.  
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Figure 3.35: Degradation for combination of CuHARS and copper nanoparticles.  
Decreasing total number of 10ug/ml CuHARS and 5ug/ml CuNPs particles in the 
same well. Error bar represents standard deviations. 
Figures 3.33 and 3.34 show sonicated 10ug/ml CuHARS and 5ug/ml CuNPs were 
degraded over 7 days in the CRL 2303 cell culture media in the incubator (37ºC). The 
number of particles decreased by 98% over 7 days. The total surface area of particles 
decreased by 94% over 7 days.  
                          3.7 Copper Nanoparticles in The Living cell environment  
Copper nanoparticles were treated with astrocyte cells and glioma rat cancer cell 
to testify how toxicity of Copper nanoparticles affect the cells’ normal growth rate. 
Figures 3.36 to 3.37 show how copper nanoparticles affect the cells’ morphologies. 
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Figure 3.36: 5ug/ml of CuNPs are treated with 10,000 astrocyte cells in the incubator 
(37ºC). The picture was taken after 20 minutes cells were treated with CuNPs. 10x 
magnification.      
 
Figure 3.37: 10,000 astrocyte cells without CuNPs in the incubator (37ºC). Picture is 
a control to compare with CuNPs treated with the cells.  The picture is taken 20 mins 
after other wells were treated with CuNPs.  
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Figure 3.38: 5ug/ml of CuNPs are treated with 10,000 astrocyte cells in the incubator 
(37ºC). The picture was taken 2 days after cells were treated with CuNPs. 
 
Figure 3.39: Control cells without CuNPs. The picture was taken 2days after other 
cells were treated with CuNPs. 10x magnification.    
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Figures 3.35 and 3.37 show 10,000 astrocyte cells treated with concentration of 
5ug/ml of CuNPs to determine whether CuNPs are harmful to astrocyte cells and change 
their morphologies. These two figures show CuNPs completely disappeared within 2 
days. All CuNPs are degraded, but astrocyte cells have changed their morphologies.  
Cells in Figure 3.37 are very stressed and shrunk.  Figure 3.36 and 3.38 show cells are 
normally growing, and nothing has changed. The result shows CuNPs are impacted 
astrocyte cells.  
Figures 3.39 to Figure 3.42 show 5000 glioma rat cancer cells treated with 
concentration of 5ug/ml CuNPs. 
 
 
Figure 3.40: 5000 glioma rat cancer cells treated with 5ug/ml of CuNPs in the 
incubator (37ºC). The picture was taken 2 hours after glioma cells were treated with 
CuNPs. 10x magnification.    
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Figure 3.41: Control cells without CuNPs. The picture was taken 2 hours after other 
cells treated with CuNPs.  10x magnification.    
 
 
Figure 3.42: 5000 glioma rat cancer cells treated with 5ug/ml of CuNPs. The picture 
was taken 3days after treated with CuNPs. 10x magnification.    
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Figure 3.43: Control cells (glioma cells) without CuNPs. The picture was taken 3 
days after other cells were treated with CuNPs.  10x magnification.   
 Figures 3.39 and 3.41 show 5000 CRL 2303 glioma rat cancer cells were treated 
with 5ug/ml non-sonicated CuNPs in the incubator (37ºC) for 3 days. The result show in 
Figure 3.41 that CuNPs in the cells were completely degraded. Also, cells have changed 
their morphologies, they have grown fast, they are stressed, and cells’ volume is 
enlarged. The control cells kept growing and nothing major changed.  
3.8   Zinc Nanoparticles in Different Biological and Physical Environments 
 Micro sized Zinc-cystine microparticles were tested in the sterilized water and 
astrocyte cell culture media in the incubator (37ºC) to determine their mobility and 
activity. Figures 3.43 to 3.46 show activities of Zinc-cystine microparticles in the 
sterilized water and astrocyte cell media in the incubator (37 ºC). 
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Figure 3.44: 0.2 mM of Zinc-cystine microparticles in sterilized water in the 
incubator (37 ºC). The picture was taken 3 hours after microparticles were added into 
the plate. 10x magnification.    
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Figure 3.45: 0.2 mM of Zinc-cystine microparticles in the sterilized water at 
incubator (37 ºC). The picture was taken 5 days after microparticles were added into 
the plate. 10x magnification.    
 
Figure 3.46: 0.2 mM of Zinc-cystine microparticles in the astrocyte cell culture 
media in the incubator (37 ºC). The picture was taken 3 hours after microparticles 
were added into the plate. 10x magnification.  
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 Figures 3.43 to 3.46 show a concentration of 2mM Zinc-cystine microparticles 
tested in the sterilized water in the incubator (37ºC). Although Zinc-cystine 
microparticles were tested in different solutions, in both solutions Zinc-cystine 
microparticles aggregated slowly within 5 days. Due to different surface properties, 
particle distribution of Zinc-cystine microparticles directly affected the agglomeration 
behavior under different biological environments. When Zinc-cystine microparticles were 
added to the sterilized water and astrocyte cell culture media, microparticles were 
clumped very big that there are only two data points which can’t provide aggregation plot 
graph. Table 3.1 shows all nanoparticles’ activities in different biological environments. 
Table will be explained in discussion section.  
 
 
 
Figure 3.47: 0.2 mM of Zinc-cystine microparticles in the astrocyte cell culture 
media in the incubator (37 ºC). The picture was taken 5 days after microparticles were 
added into the plate. 
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Table 3.1: All nanoparticles’ physical behaviors in different physiological environments 
Particles  Sterilize
d water 
Deionize
d water  
Astrocyt
e media  
CRL 
2303 
media 
Astrocyte 
cells  
CRL 2303 
Cells 
FeNPs Aggregat
e  
Stable  aggregate ____ Aggregate/n
ot harmful to 
the cells  
Aggregate/n
ot harmful to 
the cells 
CuNPs Aggregat
e 
Break 
down 
Degrade  Degrad
e 
Degrades/ 
harmful to 
the cells  
Degrades/ 
not harmful 
to the cells  
CuHAR
S 
Stable Stable  Degrade Degrad
e  
Degrades/ 
harmful to 
the cells 
Degrades/ 
not harmful 
to the cells 
ZnNPs Aggregat
e 
____ Aggregat
e  
____ ____ ____ 
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CHAPTER 4 
 
DISCUSSION  
 
 
In this study, different types of metal related nanoparticles were tested in different 
biological environments to investigate their morphology change, stability, mobility and 
activity. Due to nanomaterials having huge surface area per unit volume, they are 
biocompatible, stable, aggregating and degrading under different physiological 
conditions.  
Iron nanoparticles were tested with sterilized water, deionized water, astrocyte 
cell culture media and DPBS1x solution. Only iron nanoparticles in deionized water did 
not change their morphology, they were stable. However, iron nanoparticles in sterilized 
water, astrocyte cell culture media, and DPBS1x solution formed chain-like aggregates. 
The surface charge or the zeta potential of iron nanoparticles has important implications 
on their suspension stability and mobility in water environment. Aquifer materials 
generally have universal negative surface charge in the neutral pH range. Hence, the iron 
nanoparticles with positive charge at pH lower than 8.3 are attractive to aquifer materials 
[11]. Sterilized water, astrocyte cell culture media, and DPBS1x solution have lower pH 
than iron nanoparticles, which can explain the apparent aggregation of iron nanoparticles 
and low mobility. When astrocyte cells and CRL 2303 cells were treated with sonicated 
iron nanoparticles, they didn’t change their morphologies, and the cells were growing  
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normally. Iron nanoparticles aggregated and attached to the cell membrane, which didn’t 
harm the cells. 
Copper nanoparticles were tested with sterilized water, deionized water, and 
astrocyte cell culture media. Copper nanoparticles in sterilized water exhibited highly 
aggregated morphology. Aggregated size is influenced by ionic strength (IS) and pH via 
charge regulation, whereby the effective repulsive surface charge of the copper 
nanoparticles is decreased through ionic shielding and surface de/protonation [12]. 
Surface characterization of copper nanoparticles control their surface charge and potential 
interactions with environmental components, which play critical roles in determining 
nanoparticles aggregation [3]. Copper nanoparticles in deionized water didn’t aggregate 
due to deionized water having neutral pH, zeta potential of copper nanoparticles didn’t 
change. However, copper nanoparticles in deionized water changed the color due to 
changing of their dielectric properties and size.   
Morphology of copper nanoparticles is one of the important properties affecting 
their toxicity. Copper nanoparticles added to astrocyte cells and glioma rat cancer cells 
which affected the cells’ growth, metabolism, and replication. Copper nanoparticles 
attached to the cell environment produce high amounts of reactive oxygen species (ROS). 
Numerous studies have considered ROS generation as the major cause of nanotoxicity 
[7]. The copper nanoparticles generated ROS, leading to lipid peroxidation, DNA 
damage, protein oxidation, and interaction with cell membrane via electrostatic 
interaction resulting in disruption of cell functions [4].  
 CuHASRS and CuNPs in astrocyte cell culture media degrade in different 
degrees. CuNPs degrade faster, so within 12 hours CuNPs completely disappeared. 
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However, CuHARS materials are largely non-aggregating in many aqueous conditions 
and are less toxic to cells than CuNPs. This could be benefit for CuHARS and CuNPs are 
biodegradable in certain cell culture media that contains fetal bovine or horse sera. likely 
copper binding proteins to be considered could include ceruloplasmin which us a serum 
ferroxidase that contains 95% of the copper found in plasma, and albumin, which also has 
copper binding properties [9].  
Zinc-cystine microparticles were tested in sterilized water and astrocyte cell 
culture media, and different shape and size of Zinc-cystine microparticles aggregated 
over time. The charge released from Zinc-cystine microparticles and their electrophoretic 
mobility determined the aggregation of the nanoparticles. 
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CHAPTER 5 
 
CONCLUSIONS AND FUTURE WORK 
 
 
5.1 Conclusions 
Nano sized metal related nanoparticles have unique physical and chemical 
properties; fully understanding and predicting their environmental behaviors remains 
challenging [3]. The critical factors determining the mobility of CuNPs, CuHARS, 
FeNPs, and ZnNPs include their speciation, size, surface charge and physical and 
chemical condition of the environmental medium. CuNPs, FeNPs, and ZnNPs are 
aggregated in sterilized water. CuHARS and CuNPs are degraded in astrocyte and CRL 
2303 cell culture media in different degrees. Due to deionized water having neutral pH, 
which nanoparticles didn’t aggregate.  
For toxicity evaluation, identifying whether the toxicity is due to charge release or 
interaction with cells, or both combinations is really challenging. CuNPs and CuHARS 
have negative impact on astrocyte cells and CRL 2303 glioma rat cancer cells. When 
astrocyte cells and CRL 2303 glioma rat cancer cells were treated with CuNPs and 
CuHARS, particles attached to the membrane. In the cell environment CuNPs and 
CuHARS produce ROS, which disturbs normal function of the cells, so eventually the 
cells will die. Also, astrocyte cells and CRL 2303 glioma rat cancer cells were treated 
with FeNPs. After FeNPs attached to the cells, the cells were normally growing. FeNPs 
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did not harm the cells.  
                                                         5.2 Future Work 
Nanotechnology has been considered as a key component of sustainable 
development. However, the promise of nanotechnology can only be achieved if the 
exposure and toxicity can be fully evaluated and properly managed [3]. Metal-based 
nanoparticles exhibit good cellular interactions with biomolecules within the cell and on 
cell surfaces. They can also be engineered by introducing selected biological moieties 
with specific binding activity to selected targets [4]. Due to most of the metal- related 
nanoparticles having toxicity by nature, they can be used for anti-bacterial, anti-infection, 
anti-viral drugs, and other therapy applications.  
Metal- related nanoparticles have important roles in targeted drug delivery fields. 
In this technique, nanoparticles maybe attached to a selective drug delivery system that 
will help therapeutic efficacy, bio availability and biodistribution. However, in order for 
metal-related nanoparticles to continue to be used in the targeted drug delivery field, a 
multidisciplinary approach is required from both basic and clinical research backgrounds 
to achieve sustained innovation [13].  
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APPENDIX A  
 
ASTROCYTE CULTURE MEDIA 
 
 
For 250mL total media, use the following amounts: 
• 12.5mL Horse serum (5.0%) 
• 12.5mL Fetal Bovine Serum [FBS] (0.5%) 
• 12.5mL Penicillin/Streptomycin [P/S] (0.5%) 
• 223.75Ml Ham’s F-12K media with L-Glutamine (89.5%) 
In a sterile environment, add the component together in the following manner: 
1. Add 100mL of Ham’s F-12K media to sterile vacuum filtration unit. 
2. Add horse serum, FBS, and P/S to vacuum filtration unit.  
3. Add 123.5 mL of Ham’s F-12K media to unit.  
4. Place cap on unit, carefully turn on vacuum  
5. Allow the liquid to pass through the filter, turn off vacuum before bubbles 
from 
6. Once vacuum is off, remove cap and place screw on cap on the container  
7. Label media including name and date made, store in refrigerator  
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APPENDIX B  
 
CRL 2303 CULTURE MEDIA 
 
 
For 250 mL total media, use the following amounts: 
• 25 mL of Fetal Bovine Serum [FBS] 
• 2.5 mL Amino acid Solution (1%) 
• 221.5 mL Dulbecco’s Modified Eagle’s Medium [DMEM] 
• 1.25 mL Penicillin/Streptomycin [P/S] solution (0.5%) 
In sterile environment, add the component together in the following manner: 
1. Add 110.25 mL DMEM to sterile filtration unit 
2. Add Fetal Bovine Serum, Amino acid solution, and P/S to sterile filtration 
unit 
3. Add 111 mL DMEM to sterile filtration  
4. Place the lit over sterile filtration unit and connect it to vacuum nozzle  
5. Carefully turn on the vacuum and allow the liquid to pass through the 
filter. Make sure to hold sterile filtration unit during this step so that unit 
dose not turn over 
6.      Twist top of the filtration unit off carefully. Screw sterile cap onto 
container of media  
7. Label media including name and date made, store in refrigerator  
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APPENDIX C  
 
IMAGE -J  
 
 
1. Open image J 
2. Go to file → Open→ Select the image 
3. Convert the image to 8bit  
4. Go to analyze and the set the scale distance for 1 pixel  
5. Adjust the thresh hold of the image and set to white and black apply it  
6. Go to analyze →analyze particles  
7. Display results  
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Figure C.1: An example of image analysis to justify thresh hold of the image.   
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Figure C.2: An example of image analysis to calculate CuNPs’ total surface area and 
the number of particles.  
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